MARC SIEGEL: In South Korea, they're testing 20,000 people a day and they know exactly how many cases they have. And they're busy giving them different antiviral treatments. They're trying Plaquenil, which is a rheumatological drug. They're trying chloroquine. They're trying remdesivir. They're trying these drugs, and they're starting to slow the spread. That's what we should be doing.